Financials

News Discussions Technicals Seasonals

2CUREX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

2cureX AB engages in the research and development of anti-cancer treatments. It offers IndiTreat, which is a tool that determines treatment methods on individual colorectal cancer patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Copenhagen, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

2CUREX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company